Umbralisib - TG Therapeutics
At a glance
- Drug Originator Incozen Therapeutics; Rhizen Pharmaceuticals
- Drug Licenced by TG Therapeutics Inc
- Drug Class Amines; Antineoplastics; Benzopyrans; Fluorinated hydrocarbons; Ketones; Pyrazoles; Pyrimidines; Small molecules
- Mechanism of Action Casein kinase 1 epsilon inhibitors; Phosphatidylinositol 3 kinase delta inhibitors
- USA Patent Applicants TG THERAPS
- USA Patents 9
- NDAs 1
- International Patents 68
- Patent Applications 26
Disclaimer